📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Ossiform

1.1 - Company Overview

Ossiform Logo

Ossiform

Headquarter: Denmark
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of 3D bone printing solutions, including P3D Bone - bio-integrative, resorbable implants made from beta-tricalcium phosphate tailored to biomechanical needs; P3D Scaffolds - 3D printed bioceramic structures for cell culture, disease modeling, and drug screening; and Bone Printing Technology using beta-tricalcium phosphate to create implants with customizable porosity and mechanical properties.

Products and services

  • P3D Bone: A 3D printed, bio-integrative bone implant fabricated from beta-tricalcium phosphate that supports regeneration and controlled resorption, tailored to patient-specific biomechanical requirements
  • Bone Printing Technology: An additive-manufactured 3D printing technique using a beta-tricalcium phosphate bio-ink to fabricate resorbable implants with customizable porosity and tunable mechanical properties for precise anatomical applications
  • P3D Scaffolds: Research-grade 3D printed bioceramic scaffolds that mimic native bone structure, enabling cell culture, disease modeling, and drug screening workflows for in vitro studies and preclinical assay development

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Ossiform

SeqLL Logo

SeqLL

HQ: United States Website
  • Description: Provider of molecule sequencing technology for research and healthcare communities.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SeqLL company profile →
Applied StemCell Logo

Applied StemCell

HQ: United States Website
  • Description: Provider of animal and cell line models as tools for drug discovery and diagnostics, leveraging proprietary TARGATT gene modification technology to create site-specific knock-in mouse, rat, and human cell line models quickly and efficiently for the pharmaceutical and academic community.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Applied StemCell company profile →
BioLegend Logo

BioLegend

HQ: United States Website
  • Description: Provider of immunological reagents for biomedical research, developing antibodies, recombinant proteins, bioassays, and other research reagents at a state-of-the-art facility in San Diego, California.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioLegend company profile →
SenesTech Logo

SenesTech

HQ: United States Website
  • Description: Provider of agricultural biotechnology life-sciences solutions for managing animal pest populations through fertility. Offers ContraPest, an EPA-registered liquid contraceptive that reduces rat fertility to control infestations, and Evolve, a soft bait that interferes with rodent reproductive mechanisms to prevent population growth.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SenesTech company profile →
Mabtech Logo

Mabtech

HQ: Sweden Website
  • Description: Provider of monoclonal antibodies and immunoassay kits for ELISA, ELISpot, and FluoroSpot; automated readers (Mabtech IRIS 2 for ELISpot, FluoroSpot, and FociSpot; Mabtech ASTOR 2 for ELISpot) for spot counting and data analysis; and reagents including peptide pools, polyclonal stimuli, buffers, substrates, plates, and antibodies to cytokines, immunoglobulins, and apolipoproteins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mabtech company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Ossiform

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Ossiform

2.2 - Growth funds investing in similar companies to Ossiform

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Ossiform

4.2 - Public trading comparable groups for Ossiform

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Ossiform

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Ossiform

What does Ossiform do?

Ossiform is a provider of 3D bone printing solutions, including P3D Bone - bio-integrative, resorbable implants made from beta-tricalcium phosphate tailored to biomechanical needs; P3D Scaffolds - 3D printed bioceramic structures for cell culture, disease modeling, and drug screening; and Bone Printing Technology using beta-tricalcium phosphate to create implants with customizable porosity and mechanical properties.

Who are Ossiform's competitors?

Ossiform's competitors and similar companies include SeqLL, Applied StemCell, BioLegend, SenesTech, and Mabtech.

Where is Ossiform headquartered?

Ossiform is headquartered in Denmark.

How many employees does Ossiform have?

Ossiform has 1,000 employees 🔒.

When was Ossiform founded?

Ossiform was founded in 2010 🔒.

What sector and industry vertical is Ossiform in?

Ossiform is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Ossiform

Who are the top strategic acquirers in Ossiform's sector and industry

Top strategic M&A buyers and acquirers in Ossiform's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Ossiform?

Top strategic M&A buyers groups and sectors for Ossiform include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Ossiform's sector and industry vertical

Which are the top PE firms investing in Ossiform's sector and industry vertical?

Top PE firms investing in Ossiform's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Ossiform's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Ossiform's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Ossiform's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Ossiform include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Ossiform's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Ossiform?

The key public trading comparables and valuation benchmarks for Ossiform include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Ossiform for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Ossiform with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Ossiform's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Ossiform with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Ossiform's' sector and industry vertical?

Access recent funding rounds and capital raises in Ossiform's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Ossiform